(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/06/21 | 日証協 | 306,300株 | -6.1% | 101,321株 | -2.29% | 290,576株 | -7.31% | 28,900株 | -16.47% |
2019/06/14 | 日証協 | 326,200株 | +8.84% | 103,700株 | +53.4% | 313,476株 | +7.69% | 34,600株 | +214.37% |
2019/06/07 | 日証協 | 299,700株 | +2.1% | 67,600株 | +82.98% | 291,082株 | +1.86% | 11,006株 | -73.75% |
2019/05/31 | 日証協 | 293,550株 | -12.78% | 36,944株 | -43.05% | 285,776株 | -1.58% | 41,920株 | +10.95% |
2019/05/24 | 日証協 | 336,553株 | -8.59% | 64,870株 | -78.46% | 290,352株 | -1.65% | 37,782株 | -72.07% |
2019/05/17 | 日証協 | 368,160株 | +193.82% | 301,110株 | +358.95% | 295,226株 | +63.76% | 135,251株 | +179.33% |
2019/05/10 | 日証協 | 125,300株 | +35.46% | 65,609株 | +122.45% | 180,276株 | +17% | 48,419株 | +256.02% |
2019/04/26 | 日証協 | 92,500株 | +31.77% | 29,494株 | +211.25% | 154,076株 | +11.91% | 13,600株 | -12.82% |
2019/04/19 | 日証協 | 70,200株 | -66.14% | 9,476株 | -20.6% | 137,676株 | -36.69% | 15,600株 | +119.41% |
2019/04/12 | 日証協 | 207,336株 | +3.2% | 11,935株 | -46.89% | 217,476株 | +1.07% | 7,110株 | -76.14% |
2019/04/05 | 日証協 | 200,900株 | +9.96% | 22,472株 | -37.05% | 215,178株 | +7.66% | 29,805株 | +331.83% |
2019/03/29 | 日証協 | 182,700株 | -3.55% | 35,700株 | +3933.9% | 199,876株 | -4.67% | 6,902株 | +228.67% |
2019/03/22 | 日証協 | 189,415株 | -6.28% | 885株 | -41% | 209,676株 | -2.92% | 2,100株 | -94.32% |
2019/03/15 | 日証協 | 202,115株 | -5.51% | 1,500株 | -93.72% | 215,976株 | -8.47% | 37,000株 | +128.4% |
2019/03/08 | 日証協 | 213,900株 | +2% | 23,880株 | +69.51% | 235,961株 | -4.38% | 16,200株 | +14.33% |
2019/03/01 | 日証協 | 209,700株 | +2.19% | 14,088株 | -55.7% | 246,766株 | -0.65% | 14,170株 | -45.99% |
2019/02/22 | 日証協 | 205,200株 | +11.46% | 31,800株 | +283.13% | 248,388株 | +5.71% | 26,234株 | +60.94% |
2019/02/15 | 日証協 | 184,100株 | -2.64% | 8,300株 | -34.65% | 234,976株 | -0.51% | 16,300株 | -32.92% |
2019/02/08 | 日証協 | 189,100株 | -3.72% | 12,700株 | -29.44% | 236,176株 | -9.68% | 24,300株 | -54.41% |
※株式分割は考慮していませんのでご注意ください。
Page Top